Folic acid is a prescription medicine indicated for the treatment of megaloblastic anemias due to folic acid deficiency in adult and pediatric patients. MedsAcross supplies Folic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
FOLIC ACID oral solution is indicated for the treatment of megaloblastic anemias due to folic acid deficiency in adult and pediatric patients. FOLIC ACID oral solution is a folate analog indicated for the treatment of megaloblastic anemias due to folic acid deficiency in adult and pediatric patients.
Source: US FDA prescribing information
Folic acid acts on megaloblastic bone marrow to produce a normoblastic marrow. In man, an exogenous source of folate is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias.
Source: US FDA prescribing information
Recommended starting dosage in adults and pediatric patients (regardless of age) is up to 1 mg orally daily. Maintenance dosage - Pediatric patients birth to 23 months: 0.1 mg orally daily - Pediatric patients 2 years to less than 4 years: up to 0.3 mg orally daily - Adults and pediatric patients 4 years and older: 0.4 mg orally daily - Pregnant and Lactating Women: 0.8 mg orally daily, but never less than 0.1 mg orally per day
Source: US FDA prescribing information
FOLIC ACID oral solution is contraindicated in patients with a history of a hypersensitivity reaction to folic acid or any of the ingredients of QUIOFIC.
Source: US FDA prescribing information
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. This may result in severe nervous system damage before the correct diagnosis is made.
Source: US FDA prescribing information
The following clinically significant adverse reactions are described elsewhere in the labeling: Risk of Obscuring Diagnosis of Pernicious Anemia The following adverse reactions associated with the use of folic acid were identified in clinical studies or post marketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Adverse Reactions: Hypersensitivity reactions including rash, itching, malaise, and bronchospasm.
Source: US FDA prescribing information
Anticonvulsant action of phenytoin is antagonized by folic acid. Multiple drug classes, including anticonvulsants, antibiotic/antimicrobial agents, folate antagonists, GI-binding agents, and oral contraceptives, may reduce folic acid absorption or folate levels.
Source: US FDA prescribing information
Store at 20°C to 25°C (68°F to 77°F). Store and dispense in the original container to protect from light.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
4 presentations of Folic acid, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Folic acid 1 mg tabletOralGeneric name | — | US FDA | Available on request |
| Folic acid 50 mg/10 mL injectionIntramuscular, intravenous, subcutaneousGeneric name | — | US FDA | Available on request |
| Folic acid 1 mg/5 mL oral solutionOralGeneric name | — | US FDA | Available on request |
| Quiofic 1 mg/5 mL oral solutionOral | Solubiomix | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions linked to Folic acid in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 4 presentations of Folic acid and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Folic acid, including Quiofic.
Yes. The US FDA first approved Folic acid on 2 June 1947, according to Drugs@FDA.
No listed presentation of Folic acid is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Folic acid is classified under ATC code B03BB01 (Folic acid).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.